Please assess the completion status of the following clinical trial:

Trial Title: Observation Versus Post-surgery Radiotherapy After Complete Exeresis in Soft Tissues Members Sarcoma

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Soft tissue sarcoma members histologically confirmed~* Tumor primitive complete excision with margins greater than or equal to 10 mm in the soft tissue in all directions during the initial surgery.~A sub-centimeter margin is authorized under an anatomic barrier (fascia, fascia, inter-osseous membrane, periosteum), if surgery is R0 a margin sub-centimeter depth is allowed for superficial tumors if the underlying fascia RESECTED is not invaded.~* Primitive tumors without breaking initial tumor and without tumor residue in the systematic recovery in case of incomplete initial excision margins or doubtful~* WHO less than or equal to 2~* Age greater than or equal to 18 years~* Review extension negative (normal chest CT)~* Information and monitoring possible~* Patient affiliated to social security~Exclusion Criteria:~* Previously treated local sarcoma relapse~* Visceral or lymph node metastases~* pre-operative treatment (chemotherapy or radiotherapy)~* PNET, alveolar rhabdomyosarcoma, Darrier-Ferrand sarcoma~* excision margins of less than 10 mm in one direction or doubtful or unspecified, except under an anatomic barrier (fascia, fascia, inter-osseous membrane, periosteum), if surgery is R0 and tumors if the superficial fascia underlying RESECTED is not invaded.~* Break-tumor during the initial surgery, or residual tumor at second surgery~* Chemotherapy~* Delay between surgery R0 margins greater than or equal to 1 cm (initial surgery or recovery) and the start of radiotherapy exceeding 8 weeks~* History of radiation on the Member~* History of cancer (except carcinoma in situ of the cervix and basal cell skin cancer or in complete remission for over 5 years)~* Pregnant Women~* Patients under guardianship or curatorship

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Absence of Radiotherapy (Type: EXPERIMENTAL): No Radiotherapy; Simple monitoring without active treatment
- Radiotherapy (Type: ACTIVE_COMPARATOR): Radiotherapy

Based on this trial design, predict the completion outcome and termination type (if applicable).